A Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy

Overview

Colonoscopy is a key technique in the detection and diagnosis of lower gastrointestinal diseases. High quality endoscopy results in better disease outcomes. However, the operant level of different endoscopists is significantly different.This study aims to construct a real-time quality monitoring system based on computer vision, named Endo.Angel, which is used to monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.

Full Title of Study: “A Prospective, Randomized, Single-blind, Parallel-controlled Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Diagnostic
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: November 30, 2019

Detailed Description

This study aims to construct a real-time quality monitoring system based on computer vision, named Endo.Angel, which is used to monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.Criteria for inclusion and exclusion are determined prior to endoscopic examination. Candidates who meet all inclusion criteria as well as do not meet all exclusion criteria are bring into the study. Participants randomized before the examination, they are divided into the exposed group assisted by Endo.Angel or the non-exposed group without Endo.Angel. Followup are conducted after the examination.Study will be finished when all followup is done,and the examination result collected from participants will send to an independent review data analysis group.

Interventions

  • Diagnostic Test: colonoscopy with assistance of Endo.Angel
    • Patients in exposed group will receive colonoscopy with assistance of Endo.Angel,a real-time quality monitoring system based on computer vision,which is used to monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.
  • Diagnostic Test: colonoscopy without assistance of Endo.Angel
    • Patients in non-exposed group will receive colonoscopy without assistance of Endo.Angel.

Arms, Groups and Cohorts

  • Experimental: exposed group
    • patients will receive colonoscopy with assistance of Endo.Angel
  • Sham Comparator: non-exposed group
    • patients will receive colonoscopy without assistance of Endo.Angel

Clinical Trial Outcome Measures

Primary Measures

  • Adenoma detection rate
    • Time Frame: 3 months
    • The numerator is the number of cases of adenoma detected by colonoscopy, and the denominator is the total number of cases of patients undergoing colonoscopy.

Secondary Measures

  • The mean number of polyps per procedure
    • Time Frame: 3 months
    • The numerator is the total number of polyps detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
  • Polyp Detection Rate
    • Time Frame: 3 months
    • The numerator is the number of patients with polyps detected by colonoscopy, and the denominator is the total number of patients receiving colonoscopy.
  • The mean number of adenomas per procedure
    • Time Frame: 3 months
    • The numerator is the total number of adenomas detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
  • Detection rate of large, small and minimal polyps
    • Time Frame: 3 months
    • The numerator was the number of patients with large (≥10 mm), small (4-9 mm), and minimal(≤5 mm) polyps detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy
  • The mean number of large, small and minimal polyps per procedure
    • Time Frame: 3 months
    • The numerator was the number of large (≥10 mm), small (4-9 mm), and minimal (≤5 mm) polyps detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
  • Detection rate of large, small and minimal adenomas
    • Time Frame: 3 months
    • The numerator was the number of patients with large (≥10 mm), small (4-9 mm), and minimal(≤5 mm) adenomas detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy
  • The mean number of large, small and minimal adenomas per procedure
    • Time Frame: 3 months
    • The numerator was the number of large (≥10 mm), small (4-9 mm), and minimal (≤5 mm) adenomas detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
  • Detection rate of adenoma in different sites
    • Time Frame: 3 months
    • The numerator is the number of cases of adenoma detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon and ileocecal region during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
  • The mean number of adenomas in different sites per procedure
    • Time Frame: 3 months
    • The numerator is the total number of adenomas detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon and ileocecal region during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
  • Time of colonoscopic withdrawal
    • Time Frame: 3 months
    • the duration of colonoscopic withdrawal(not include the time of biopsy or treatment).
  • Time of colonoscopic insertion
    • Time Frame: 3 months
    • The time of colonoscopy from the rectum to the ileocecal area.
  • The rate of reaching the ileocecal region
    • Time Frame: 3 months
    • The numerator is the number of cases of colonic examination reaching the ileocecal region, and the denominator is the total number of colonoscopy cases.

Participating in This Clinical Trial

Inclusion Criteria

1. Male or female aged 18 years or above; 2. Colonoscopy is needed to further characterize gastrointestinal diseases; 3. Ability to read, understand and sign informed consent forms; 4. The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures. Exclusion criteria:

1. Participated in other clinical trials, signed informed consent forms and followed up in other clinical trials. 2. Participate in a drug clinical trial and during the elution period of the trial or control drug 3. Drug or alcohol abuse or mental disorder in the last 5 years; 4. Pregnant or lactating women; 5. Patients with multiple polyp syndrome; 6. Patients with known space-occupying tumor or intestinal stenosis; 7. Patients with known perforation or colonic obstruction; 8. A history of anaphylaxis with antispasmodic has been documented; 9. The researchers did not consider the subjects suitable for colonoscopy; 10. The researchers determined that the subjects had high-risk diseases or other special conditions that were not appropriate for clinical trials.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Renmin Hospital of Wuhan University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Yu Honggang, Chief of Department of Gastroenterology – Renmin Hospital of Wuhan University
  • Overall Contact(s)
    • Honggang Yu, MD, +8613871281899, yuhonggang1968@163.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.